Understanding Meniere's Disease

Meniere's disease is a disorder of the inner ear that causes episodes of vertigo, fluctuating hearing loss, tinnitus, and a feeling of fullness or pressure in the ear. The condition is thought to relate to an abnormal buildup of fluid called endolymph in the inner ear chambers. While the exact cause remains unclear, managing symptoms is the main goal of treatment.

Conventional therapy includes dietary changes, especially reducing salt, along with oral diuretics and vestibular suppressants. For many patients, these measures are not enough. When vertigo attacks continue, more invasive treatments may be considered. One of the newer options is intratympanic steroid therapy, which places corticosteroid medication directly into the middle ear near the inner ear.

What Are Intratympanic Steroids?

Intratympanic steroids are medications such as dexamethasone or methylprednisolone that are injected through the eardrum into the middle ear space. The medication then diffuses through the round window membrane into the inner ear. This delivery method allows a high concentration of the steroid to reach the inner ear while minimizing systemic side effects.

The steroid works by reducing inflammation and altering immune responses in the inner ear. It is also believed to help regulate fluid balance and improve blood flow. These effects are particularly relevant in Meniere's disease, where inflammatory processes may contribute to symptoms.

The Procedure

An intratympanic injection is typically performed in a clinic or outpatient setting. The ear canal is cleaned, and the eardrum is numbed with a local anesthetic. A small needle is then used to inject the steroid solution through the eardrum into the middle ear. The patient may be asked to lie still and avoid swallowing for a few minutes so the solution remains in contact with the round window.

A single treatment may be sufficient, but a course of injections over several weeks is sometimes recommended. The number of injections depends on the patient's response and the severity of symptoms. The procedure is generally well tolerated and takes only a few minutes.

Effectiveness in Meniere's Disease

Clinical evidence suggests that intratympanic steroid injections can reduce the frequency and severity of vertigo attacks in many patients with Meniere's disease. Some studies also report improvement in hearing and tinnitus, although results vary. The treatment appears to be most effective when used during or shortly after an acute attack.

Compared with intratympanic gentamicin, which destroys inner ear balance cells, steroids are non-destructive. This makes them an attractive option for patients who wish to preserve residual hearing. For this reason, intratympanic steroid therapy is often recommended before chemical ablation or surgery.

Who May Benefit

Intratympanic steroids may be considered for patients with Meniere's disease who continue to experience vertigo despite conservative treatment. They are also used to treat sudden hearing loss and some other inner ear conditions. In Meniere's disease, the best candidates are those with intact hearing and episodes of vertigo that are not controlled by oral medication.

Patients with bilateral Meniere's disease, or those who cannot tolerate systemic steroids due to diabetes or other conditions, may also benefit from the local injection approach. The treatment is less invasive than surgery and carries a lower risk of complications than destructive procedures.

Risks and Side Effects

Intratympanic steroid injections are generally safe, but there are some potential risks. Common temporary effects include pain at the injection site, dizziness, and a feeling of fluid in the ear. The eardrum may remain slightly perforated, though this usually heals on its own.

• Ear infection
• Persistent eardrum perforation
• Worsening of hearing in rare cases
• Temporary balance problems
• Tinnitus change

Because the steroid dose is local, serious systemic side effects are uncommon. Patients should discuss the potential risks and benefits with their physician before deciding on this treatment.

Conclusion

Intratympanic steroid therapy is a valuable option in the management of Meniere's disease. It offers a minimally invasive way to deliver powerful anti-inflammatory treatment directly to the inner ear. For patients with persistent vertigo and a desire to preserve hearing, intratympanic steroids represent an important step between oral medications and more destructive interventions.

Ongoing research continues to refine patient selection, dosing schedules, and long-term outcomes. As with any medical treatment, decisions should be made together with an experienced ear, nose, and throat specialist.